- Q1 2024 VolitionRX Ltd Earnings Call TranscriptMay 14, 2024$0.75 (-14.53%)Earnings
- Q4 2023 VolitionRX Ltd Earnings Call TranscriptMar 26, 2024$0.7498 (+4.14%)Earnings
- VolitionRX Ltd Data Insights Webinar TranscriptOct 26, 2023
- VolitionRX Ltd at LD Micro Main Event XVI Conference TranscriptOct 04, 2023
- Q2 2023 VolitionRX Ltd Earnings Call TranscriptAug 15, 2023$1.21 (-1.63%)Earnings
- VolitionRX Ltd Capital Market Day TranscriptMay 11, 2023
- Q1 2023 VolitionRX Ltd Earnings Call TranscriptMay 11, 2023$1.89 (-1.05%)Earnings
- Q4 2022 VolitionRX Ltd Earnings Call TranscriptMar 16, 2023$1.72 (+11.69%)Earnings
- VolitionRX Ltd at OTC Markets Life Science Investor Forum (Virtual) TranscriptMar 09, 2023
- VolitionRX Ltd at Sidoti & Company January Micro-Cap Virtual Conference TranscriptJan 19, 2023
- VolitionRX Ltd at Issuer Direct Planet MicroCap Showcase (Virtual) TranscriptDec 07, 2022
- Q3 2022 VolitionRX Ltd Earnings Call TranscriptNov 15, 2022$1.76 (+6.02%)Earnings
- VolitionRX Ltd at OTC Markets Life Sciences Investor Forum TranscriptSep 15, 2022
- Q2 2022 VolitionRX Ltd Earnings Call TranscriptAug 11, 2022$2.02Earnings
- Q1 2022 VolitionRX Ltd Earnings Call TranscriptMay 12, 2022$2.11 (-9.83%)Earnings
- Q4 2021 VolitionRX Ltd Earnings Call TranscriptMar 31, 2022$3.01 (-7.10%)Earnings
- Q3 2021 VolitionRX Ltd Earnings Call TranscriptNov 11, 2021$3.68 (+2.22%)Earnings
- VolitionRX Ltd at SNN Network Summer Event (Virtual) TranscriptAug 18, 2021
- Q2 2021 VolitionRX Ltd Earnings and Business Update Call TranscriptAug 12, 2021
- Q1 2021 VolitionRX Ltd Earnings Call TranscriptMay 12, 2021$3.16 (+0.96%)Earnings
- Q3 2020 VolitionRX Ltd Earnings Call TranscriptNov 13, 2020$3.46 (+7.45%)Earnings
- VolitionRx Limited Presentation at the Rocky Mountain Microcap Conference VI TranscriptNov 13, 2020
- VolitionRX Ltd To Provide Corporate Update TranscriptOct 14, 2020
- VolitionRX Ltd To Present At GCFF TranscriptSep 10, 2020
- VolitionRX Ltd At SNN Network TranscriptAug 19, 2020
- Q1 2020 VolitionRX Ltd Earnings Call TranscriptMay 08, 2020$4.16 (-0.72%)Earnings
- VolitionRx Ltd. Webcast SNN Network TranscriptApr 29, 2020
- Q4 2019 VolitionRX Ltd Earnings Call TranscriptFeb 21, 2020$4.57 (-8.23%)Earnings
- Q3 2019 VolitionRX Ltd Earnings Call TranscriptNov 13, 2019$5.36 (+3.28%)Earnings
VolitionRX Ltd Data Insights Webinar Transcript
Hello. I'm Soo Romanoff. I'm here with the Volition team, and we're excited to share some of their developments in early cancer detection screening.
The Volition team's prepared a video presentation, and we'll share that with you shortly. It will be followed up with Q&A with Louise Batchelor, Group Chief Marketing and Communications Officer; Jake Micallef, Chief Scientific Officer; and Dr. Andrew Retter, a leading UK-based hematologist and medical consultant to Volition. (Event Instructions)
Without further ado, let's get started.
(video starts)
Well, good morning and good afternoon. I'm Gael Forterre, the Chief Commercial Officer of Volition. It's a pleasure to welcome you to this webinar today and to introduce you to Dr. Jake Micallef, our Chief Scientific Officer; and Dr. Andrew Retter for their presentations on the breakthrough cancer detection method.
Before the detailed science, a few words. Our mission is to save
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)